Elsevier

Virology

Volume 184, Issue 2, October 1991, Pages 645-654
Virology

The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay

https://doi.org/10.1016/0042-6822(91)90434-DGet rights and content

Abstract

The genomic variability of poliovirus was examined by analyzing the restriction fragment length polymorphism of a reverse-transcribed genomic fragment amplified by the polymerase chain reaction. The fragment was a 480-nucleotide sequence of the poliovirus genome coding for the N-terminal half of the capsid protein VP1, including antigenic site 1. The identification of a pair of generic primers flanking this fragment allowed its amplification in practically all the poliovirus strains tested so far (more than 150). By using the restriction enzymes HaeIII, Ddel, and HpaII, strain-specific restriction profiles could be generated for the amplified genomic fragment of each of the six reference poliovirus strains tested: one representative wild poliovirus of each of the three serotypes (P1/Mahoney, P2/Lansing, and P3/Finland/23127/84) and the three Sabin vaccine strains. When 21 poliovirus field isolates previously identified as Sabin vaccine-related were tested, they showed restriction profiles identical to those of the originating homotypic Sabin virus, demonstrating the conservation of these profiles during virus replication in humans. These profiles could thus be used as markers for Sabin-derived genotypes. To compare the distribution of poliovirus genotypes in nature before and after the introduction of poliovirus vaccines, the restriction profiles of the amplified genomic fragment of a total of 72 strains of various geographic and temporal origins were determined. Strains isolated before the introduction of polio vaccines displayed a wide diversity of genotypes. In contrast, wild (Sabin unrelated) strains isolated after vaccine introduction, during a single epidemic in a particular geographic area, showed identical or very similar restriction profiles, indicating the circulation of predominant regional genotypes. Our results indicate that the assay we developed for the analysis of the restriction fragment length polymorphism of the poliovirus genome may be used to identify and characterize poliovirus genotypes circulating in nature.

References (43)

  • N.M. Chapman et al.

    Molecular detection and identification of enteroviruses using enzymatic amplification and nucleic acid hybridization

    J. Clin. Microbiol.

    (1990)
  • M. Chow et al.

    Synthetic peptides from four separate regions of the poliovirus type 1 capsid protein VP1 induce neutralizing antibodies

  • T. Couderc et al.

    Molecular pathogenesis of type 2 poliovirus in mice

    Eur. J. Epidemiol.

    (1989)
  • R. Crainic et al.

    Determination of type 1 poliovirus subtype classes with neutralizing monoclonal antibodies

    Dev. Biol. Stand.

    (1982)
  • R. Crainic et al.

    Natural variation of poliovirus neutralization epitopes

    Infec. lmmun.

    (1983)
  • R. Crainic et al.

    Neutralization epitope patterns on poliovirus strains isolated from paralytic cases

    Dev. Biol. Stand.

    (1984)
  • M. Ferguson et al.

    WHO collaborative study on the use of monoclonal antibodies for the intratypic differentiation of poliovirus strains

    Bull. WHO

    (1986)
  • M.J. Hogle et al.

    Three-dimensional structure of poliovirus at 2.9 A resolution

    Science

    (1985)
  • P.J. Hughes et al.

    The nucleotide sequence of a type 3 poliovirus isolated during a recent outbreak of poliomyelitis in Finland

    J. Gen. Virol.

    (1986)
  • D.D. Humphrey et al.

    Monoclonal antibodies of four different specimens for neutralization of type 1 polioviruses

    Infect. Immunol.

    (1982)
  • A.J. Jeffreys et al.

    Individual-specific ‘fingerprints’ of human DNA

    Nature (London)

    (1985)
  • Cited by (159)

    • Detection of enteroviruses in urban sewage by next generation sequencing and its application in environmental surveillance

      2020, Science of the Total Environment
      Citation Excerpt :

      VP1 RT-PCR was performed by using SuperScript III one-step RT-PCR system with Platinum Taq DNA Polymerase (Thermo Fisher Scientific, USA). Primer pair UG1/UC11 (Balanant et al., 1991) was used to amplify the entire VP1 coding region of PV isolates, and primer pairs 486/488, 040/011, 008/013, 197/011, UF1/UR1 and 040/DR1 (Oberste et al., 2000, 2006; Tao et al., 2014) were used for the amplification of entire VP1 sequence of NPEV strains. Purified PCR products (~900 nt in length) were sequenced bi-directionally with the BigDye Terminator v3.1 Cycle Sequencing kit (Applied Biosystems) and analyzed on an ABI 3130 genetic analyzer (Applied Biosystems).

    • Quantitative multiplex one-step RT-PCR assay for identification and quantitation of Sabin strains of poliovirus in clinical and environmental specimens

      2018, Journal of Virological Methods
      Citation Excerpt :

      However, most of them include more than one step to generate the final results and are not suitable for large scale analysis needed for poliovirus surveillance. Some of these methods are based on viral cDNA preparation and PCR amplification, followed by restriction endonuclease analysis, hybridization with specific oligonucleotide probes, or based on a specific amplicon size for each poliovirus serotype (Balanant et al., 1991; Buonagurio et al., 1999; Kew et al., 2002; Kilpatrick et al., 1998, 1996; Van der Avoort et al., 1995). A specific RT-PCR assay was developed used deoxyinosine degenerate primers for identification of poliovirus and was later adapted for quantitation of poliovirus based on the use of real-time PCR (Kilpatrick et al., 1998, 1996; Kilpatrick et al., 2009).

    • Poliovirus Vaccine–Live

      2017, Plotkin's Vaccines
    • Development of real-time PCR to detect oral vaccine-like poliovirus and its application to environmental surveillance

      2014, Journal of Virological Methods
      Citation Excerpt :

      The cDNA was used for polymerase chain reaction (PCR) and real-time PCR. The PCR was carried out using primers as described previously (Rico-Hesse et al., 1987; Balanant et al., 1991), which amplify 1126 bp corresponding to nucleotides (nt) from 2402 to 3527 of poliovirus type 1 (Sabin 1; GenBank ID: V01149). The PCR products were used directly for nucleotide sequence analysis using a Big Dye Terminator ver.

    View all citing articles on Scopus
    View full text